The estimated Net Worth of Blaise Coleman is at least $3.72 millió dollars as of 29 March 2022. Mr Coleman owns over 125,573 units of Endo International plc stock worth over $126,463 and over the last 8 years he sold ENDP stock worth over $0. In addition, he makes $3,595,337 as Pres és CEO & Director at Endo International plc.
Mr has made over 4 trades of the Endo International plc stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 125,573 units of ENDP stock worth $36,743 on 29 March 2022.
The largest trade he's ever made was exercising 125,573 units of Endo International plc stock on 29 March 2022 worth over $36,743. On average, Mr trades about 12,199 units every 65 days since 2017. As of 29 March 2022 he still owns at least 432,203 units of Endo International plc stock.
You can see the complete history of Mr Coleman stock trades at the bottom of the page.
Blaise Coleman is the Pres, CEO & Director at Endo International plc.
As the Pres és CEO & Director of Endo International plc, the total compensation of Mr Coleman at Endo International plc is $3,595,337. There are 2 executives at Endo International plc getting paid more, with Paul Campanelli having the highest compensation of $13,118,300.
Mr Coleman is 47, he's been the Pres és CEO & Director of Endo International plc since . There are 13 older and 2 younger executives at Endo International plc. The oldest executive at Endo International plc is Michael Hyatt, 74, who is the Independent Director.
Blaise's mailing address filed with the SEC is C/O ENDO INTERNATIONAL PLC, FIRST FL, MINERVA HOUSE, SIMMONSCOURT RD, BALLSBRIDGE, DUBLIN, L2, .
Over the last 11 years, insiders at Endo International plc have traded over $3,455,441 worth of Endo International plc stock and bought 152,347 units worth $3,901,804 . The most active insiders traders include Silva Rajiv De, Paul Campanelli és Shane Cooke. On average, Endo International plc executives and independent directors trade stock every 36 days with the average trade being worth of $12,163. The most recent stock trade was executed by Patrick A Barry on 29 March 2022, trading 59,298 units of ENDP stock currently worth $17,351.
Endo is a specialty pharmaceutical company committed to helping everyone it serves live their best life through the delivery of quality, life-enhancing therapies. Its decades of proven success come from a global team of passionate employees collaborating to bring the best treatments forward. Together, it boldly transforms insights into treatments benefiting those who need them, when they need them.
Endo International plc executives and other stock owners filed with the SEC include: